Preoperative Oral Carbohydrate Loading in Laparoscopic Gynecologic Surgery: A Randomized Controlled Trial

J Minim Invasive Gynecol. 2021 May;28(5):1086-1094.e1. doi: 10.1016/j.jmig.2020.12.002. Epub 2020 Dec 10.

Abstract

Study objective: To determine whether carbohydrate loading improves the postoperative quality of recovery (QoR) better than the midnight fasting policy in laparoscopic gynecologic surgeries.

Design: Randomized, parallel-group trial.

Setting: Tertiary university hospital.

Patients: Female patients scheduled for laparoscopic gynecologic surgery for nonmalignant gynecologic diseases.

Interventions: Eighty-eight women were randomly assigned to the midnight fasting group (nil per os, NPO group) or the carbohydrate loading group (carbohydrate group). Patients in both groups adhered to the enhanced recovery after surgery protocol except for carbohydrate intake in the carbohydrate group.

Measurements and main results: The postoperative QoR was evaluated using the QoR 15-item questionnaire on postoperative day 2. The times to readiness for discharge of the groups were compared. The QoR 15-item questionnaire scores were 97.7 ± 23.0 in the NPO group and 99.6 ± 22.4 in the carbohydrate group; they were not statistically different (p = .702). The times to readiness for discharge of both groups were also not different: 36.8 ± 12.2 hours in the NPO group and 37.6 ± 11.8 hours in the carbohydrate group (p = .684).

Conclusion: The benefit of carbohydrate beverage intake was not significant in laparoscopic gynecologic surgeries when following the enhanced recovery after surgery protocol.

Trial registration: ClinicalTrials.gov NCT03955419.

Keywords: Benign gynecologic surgery; Carbohydrate; ERAS pathway; Fast recovery; Fast-track.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Diet, Carbohydrate Loading
  • Female
  • Genital Diseases, Female*
  • Gynecologic Surgical Procedures
  • Humans
  • Laparoscopy*
  • Pain, Postoperative
  • Postoperative Period

Associated data

  • ClinicalTrials.gov/NCT03955419
  • figshare/10.6084/m9.figshare.12904535.v1